nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—PSMB10—nervous system—Behcet's disease	0.0256	0.0438	CbGeAlD
Carfilzomib—PSMB10—central nervous system—Behcet's disease	0.0247	0.0421	CbGeAlD
Carfilzomib—PSMB8—mammalian vulva—Behcet's disease	0.0243	0.0416	CbGeAlD
Carfilzomib—PSMB1—eye—Behcet's disease	0.0237	0.0405	CbGeAlD
Carfilzomib—PSMB2—eye—Behcet's disease	0.0231	0.0395	CbGeAlD
Carfilzomib—PSMB2—retina—Behcet's disease	0.0229	0.0391	CbGeAlD
Carfilzomib—PSMB5—mammalian vulva—Behcet's disease	0.0215	0.0367	CbGeAlD
Carfilzomib—PSMB1—skin of body—Behcet's disease	0.0206	0.0352	CbGeAlD
Carfilzomib—PSMB5—cardiac atrium—Behcet's disease	0.0206	0.0352	CbGeAlD
Carfilzomib—PSMB2—skin of body—Behcet's disease	0.0201	0.0343	CbGeAlD
Carfilzomib—PSMB10—brain—Behcet's disease	0.0196	0.0334	CbGeAlD
Carfilzomib—PSMB5—medulla oblongata—Behcet's disease	0.0194	0.0331	CbGeAlD
Carfilzomib—PSMB1—mammalian vulva—Behcet's disease	0.0188	0.0321	CbGeAlD
Carfilzomib—PSMB2—mammalian vulva—Behcet's disease	0.0183	0.0313	CbGeAlD
Carfilzomib—PSMB1—cardiac atrium—Behcet's disease	0.018	0.0307	CbGeAlD
Carfilzomib—PSMB5—midbrain—Behcet's disease	0.0177	0.0303	CbGeAlD
Carfilzomib—PSMB2—cardiac atrium—Behcet's disease	0.0176	0.03	CbGeAlD
Carfilzomib—PSMB5—spinal cord—Behcet's disease	0.0173	0.0296	CbGeAlD
Carfilzomib—PSMB1—medulla oblongata—Behcet's disease	0.017	0.029	CbGeAlD
Carfilzomib—PSMB2—medulla oblongata—Behcet's disease	0.0165	0.0283	CbGeAlD
Carfilzomib—PSMB1—midbrain—Behcet's disease	0.0155	0.0265	CbGeAlD
Carfilzomib—PSMB2—midbrain—Behcet's disease	0.0151	0.0258	CbGeAlD
Carfilzomib—PSMB1—spinal cord—Behcet's disease	0.0151	0.0258	CbGeAlD
Carfilzomib—PSMB2—spinal cord—Behcet's disease	0.0148	0.0252	CbGeAlD
Carfilzomib—PSMB1—nervous system—Behcet's disease	0.0127	0.0218	CbGeAlD
Carfilzomib—PSMB9—Type II interferon signaling (IFNG)—HLA-B—Behcet's disease	0.0127	0.0307	CbGpPWpGaD
Carfilzomib—PSMB8—brain—Behcet's disease	0.0126	0.0216	CbGeAlD
Carfilzomib—PSMB2—nervous system—Behcet's disease	0.0124	0.0212	CbGeAlD
Carfilzomib—PSMB1—central nervous system—Behcet's disease	0.0123	0.021	CbGeAlD
Carfilzomib—PSMB2—central nervous system—Behcet's disease	0.012	0.0205	CbGeAlD
Carfilzomib—PSMB5—brain—Behcet's disease	0.0111	0.019	CbGeAlD
Carfilzomib—PSMB9—Type II interferon signaling (IFNG)—ICAM1—Behcet's disease	0.0104	0.025	CbGpPWpGaD
Carfilzomib—PSMB1—brain—Behcet's disease	0.00974	0.0166	CbGeAlD
Carfilzomib—PSMB2—brain—Behcet's disease	0.0095	0.0162	CbGeAlD
Carfilzomib—ABCB1—Allograft Rejection—MICA—Behcet's disease	0.00895	0.0216	CbGpPWpGaD
Carfilzomib—PSMB10—Proteasome Degradation—HLA-B—Behcet's disease	0.00847	0.0204	CbGpPWpGaD
Carfilzomib—PSMB9—Proteasome Degradation—HLA-B—Behcet's disease	0.00843	0.0203	CbGpPWpGaD
Carfilzomib—PSMB10—ER-Phagosome pathway—HLA-B—Behcet's disease	0.00836	0.0202	CbGpPWpGaD
Carfilzomib—PSMB9—ER-Phagosome pathway—HLA-B—Behcet's disease	0.00832	0.0201	CbGpPWpGaD
Carfilzomib—PSMB10—Class I MHC mediated antigen processing & presentation—ERAP1—Behcet's disease	0.00812	0.0196	CbGpPWpGaD
Carfilzomib—PSMB9—Class I MHC mediated antigen processing & presentation—ERAP1—Behcet's disease	0.00808	0.0195	CbGpPWpGaD
Carfilzomib—PSMB10—Antigen processing-Cross presentation—HLA-B—Behcet's disease	0.00691	0.0167	CbGpPWpGaD
Carfilzomib—PSMB9—Antigen processing-Cross presentation—HLA-B—Behcet's disease	0.00688	0.0166	CbGpPWpGaD
Carfilzomib—ABCB1—blood vessel—Behcet's disease	0.00663	0.0113	CbGeAlD
Carfilzomib—PSMB1—Proteasome Degradation—HLA-B—Behcet's disease	0.00642	0.0155	CbGpPWpGaD
Carfilzomib—PSMB5—Proteasome Degradation—HLA-B—Behcet's disease	0.00642	0.0155	CbGpPWpGaD
Carfilzomib—PSMB2—Proteasome Degradation—HLA-B—Behcet's disease	0.00642	0.0155	CbGpPWpGaD
Carfilzomib—PSMB5—ER-Phagosome pathway—HLA-B—Behcet's disease	0.00634	0.0153	CbGpPWpGaD
Carfilzomib—PSMB2—ER-Phagosome pathway—HLA-B—Behcet's disease	0.00634	0.0153	CbGpPWpGaD
Carfilzomib—PSMB1—ER-Phagosome pathway—HLA-B—Behcet's disease	0.00634	0.0153	CbGpPWpGaD
Carfilzomib—PSMB8—Proteasome Degradation—HLA-B—Behcet's disease	0.00633	0.0153	CbGpPWpGaD
Carfilzomib—PSMB8—ER-Phagosome pathway—HLA-B—Behcet's disease	0.00625	0.0151	CbGpPWpGaD
Carfilzomib—PSMB1—Class I MHC mediated antigen processing & presentation—ERAP1—Behcet's disease	0.00616	0.0148	CbGpPWpGaD
Carfilzomib—PSMB2—Class I MHC mediated antigen processing & presentation—ERAP1—Behcet's disease	0.00616	0.0148	CbGpPWpGaD
Carfilzomib—PSMB5—Class I MHC mediated antigen processing & presentation—ERAP1—Behcet's disease	0.00616	0.0148	CbGpPWpGaD
Carfilzomib—PSMB8—Interferon alpha/beta signaling—HLA-B—Behcet's disease	0.00609	0.0147	CbGpPWpGaD
Carfilzomib—PSMB8—Class I MHC mediated antigen processing & presentation—ERAP1—Behcet's disease	0.00607	0.0146	CbGpPWpGaD
Carfilzomib—PSMB5—Antigen processing-Cross presentation—HLA-B—Behcet's disease	0.00524	0.0126	CbGpPWpGaD
Carfilzomib—PSMB1—Antigen processing-Cross presentation—HLA-B—Behcet's disease	0.00524	0.0126	CbGpPWpGaD
Carfilzomib—PSMB2—Antigen processing-Cross presentation—HLA-B—Behcet's disease	0.00524	0.0126	CbGpPWpGaD
Carfilzomib—PSMB8—Antigen processing-Cross presentation—HLA-B—Behcet's disease	0.00516	0.0124	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—ERAP1—Behcet's disease	0.00402	0.0097	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—ERAP1—Behcet's disease	0.004	0.00965	CbGpPWpGaD
Carfilzomib—ABCB1—HIF-1-alpha transcription factor network—ITGB2—Behcet's disease	0.00391	0.00944	CbGpPWpGaD
Carfilzomib—ABCB1—retina—Behcet's disease	0.0035	0.00598	CbGeAlD
Carfilzomib—PSMB2—Adaptive Immune System—ERAP1—Behcet's disease	0.00305	0.00735	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—ERAP1—Behcet's disease	0.00305	0.00735	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—ERAP1—Behcet's disease	0.00305	0.00735	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—ERAP1—Behcet's disease	0.003	0.00725	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—ITGB2—Behcet's disease	0.00297	0.00717	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—ITGB2—Behcet's disease	0.00296	0.00714	CbGpPWpGaD
Carfilzomib—PSMB8—Interferon Signaling—HLA-B—Behcet's disease	0.00284	0.00684	CbGpPWpGaD
Carfilzomib—ABCB1—mammalian vulva—Behcet's disease	0.0028	0.00478	CbGeAlD
Carfilzomib—PSMB10—Class I MHC mediated antigen processing & presentation—HLA-B—Behcet's disease	0.00276	0.00665	CbGpPWpGaD
Carfilzomib—PSMB9—Class I MHC mediated antigen processing & presentation—HLA-B—Behcet's disease	0.00275	0.00662	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—MEFV—Behcet's disease	0.00274	0.0066	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—MEFV—Behcet's disease	0.00272	0.00657	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—ITGAL—Behcet's disease	0.00268	0.00647	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—ITGAL—Behcet's disease	0.00267	0.00644	CbGpPWpGaD
Carfilzomib—ABCB1—medulla oblongata—Behcet's disease	0.00253	0.00432	CbGeAlD
Carfilzomib—ABCB1—ABC-family proteins mediated transport—APOA1—Behcet's disease	0.00249	0.00602	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—ERAP1—Behcet's disease	0.00244	0.00588	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—ERAP1—Behcet's disease	0.00243	0.00585	CbGpPWpGaD
Carfilzomib—ABCB1—midbrain—Behcet's disease	0.00231	0.00395	CbGeAlD
Carfilzomib—PSMB8—Interferon Signaling—ICAM1—Behcet's disease	0.00231	0.00556	CbGpPWpGaD
Carfilzomib—ABCB1—spinal cord—Behcet's disease	0.00225	0.00385	CbGeAlD
Carfilzomib—PSMB5—Adaptive Immune System—ITGB2—Behcet's disease	0.00225	0.00544	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—ITGB2—Behcet's disease	0.00225	0.00544	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—ITGB2—Behcet's disease	0.00225	0.00544	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—ITGB2—Behcet's disease	0.00222	0.00536	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—CTLA4—Behcet's disease	0.0021	0.00507	CbGpPWpGaD
Carfilzomib—PSMB2—Class I MHC mediated antigen processing & presentation—HLA-B—Behcet's disease	0.00209	0.00504	CbGpPWpGaD
Carfilzomib—PSMB5—Class I MHC mediated antigen processing & presentation—HLA-B—Behcet's disease	0.00209	0.00504	CbGpPWpGaD
Carfilzomib—PSMB1—Class I MHC mediated antigen processing & presentation—HLA-B—Behcet's disease	0.00209	0.00504	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—MEFV—Behcet's disease	0.00207	0.005	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—MEFV—Behcet's disease	0.00207	0.005	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—MEFV—Behcet's disease	0.00207	0.005	CbGpPWpGaD
Carfilzomib—PSMB8—Class I MHC mediated antigen processing & presentation—HLA-B—Behcet's disease	0.00206	0.00497	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—MEFV—Behcet's disease	0.00204	0.00493	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—ITGAL—Behcet's disease	0.00203	0.0049	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—ITGAL—Behcet's disease	0.00203	0.0049	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—ITGAL—Behcet's disease	0.00203	0.0049	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—ITGAL—Behcet's disease	0.002	0.00483	CbGpPWpGaD
Carfilzomib—ABCB1—nervous system—Behcet's disease	0.0019	0.00325	CbGeAlD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—HLA-B—Behcet's disease	0.00189	0.00457	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—ERAP1—Behcet's disease	0.00185	0.00446	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—ERAP1—Behcet's disease	0.00185	0.00446	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—ERAP1—Behcet's disease	0.00185	0.00446	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—CTLA4—Behcet's disease	0.00185	0.00445	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—CTLA4—Behcet's disease	0.00184	0.00443	CbGpPWpGaD
Carfilzomib—ABCB1—central nervous system—Behcet's disease	0.00183	0.00312	CbGeAlD
Carfilzomib—PSMB8—Immune System—ERAP1—Behcet's disease	0.00182	0.00439	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—ITGB2—Behcet's disease	0.0018	0.00435	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—ITGB2—Behcet's disease	0.0018	0.00433	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—IL10—Behcet's disease	0.00164	0.00395	CbGpPWpGaD
Carfilzomib—PSMB10—Apoptosis—TNF—Behcet's disease	0.00163	0.00393	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—ITGAL—Behcet's disease	0.00163	0.00392	CbGpPWpGaD
Carfilzomib—PSMB9—Apoptosis—TNF—Behcet's disease	0.00162	0.00391	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—ITGAL—Behcet's disease	0.00162	0.00391	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—HLA-B—Behcet's disease	0.00156	0.00375	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—ICAM1—Behcet's disease	0.00154	0.00371	CbGpPWpGaD
Carfilzomib—ABCB1—brain—Behcet's disease	0.00145	0.00248	CbGeAlD
Carfilzomib—PSMB1—Adaptive Immune System—CTLA4—Behcet's disease	0.0014	0.00337	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CTLA4—Behcet's disease	0.0014	0.00337	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CTLA4—Behcet's disease	0.0014	0.00337	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CTLA4—Behcet's disease	0.00138	0.00333	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—ITGB2—Behcet's disease	0.00137	0.0033	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—ITGB2—Behcet's disease	0.00137	0.0033	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—ITGB2—Behcet's disease	0.00137	0.0033	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—HLA-B—Behcet's disease	0.00137	0.00329	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—HLA-B—Behcet's disease	0.00136	0.00328	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—ITGB2—Behcet's disease	0.00135	0.00325	CbGpPWpGaD
Carfilzomib—PSMB5—Apoptosis—TNF—Behcet's disease	0.00123	0.00298	CbGpPWpGaD
Carfilzomib—PSMB1—Apoptosis—TNF—Behcet's disease	0.00123	0.00298	CbGpPWpGaD
Carfilzomib—PSMB2—Apoptosis—TNF—Behcet's disease	0.00123	0.00298	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—ITGAL—Behcet's disease	0.00123	0.00297	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—ITGAL—Behcet's disease	0.00123	0.00297	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—ITGAL—Behcet's disease	0.00123	0.00297	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CCR1—Behcet's disease	0.00123	0.00296	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CCR1—Behcet's disease	0.00122	0.00294	CbGpPWpGaD
Carfilzomib—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—Behcet's disease	0.00122	0.00294	CbGpPWpGaD
Carfilzomib—PSMB8—Apoptosis—TNF—Behcet's disease	0.00122	0.00293	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—ITGAL—Behcet's disease	0.00122	0.00293	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CTLA4—Behcet's disease	0.00112	0.0027	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CTLA4—Behcet's disease	0.00111	0.00269	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—ICAM1—Behcet's disease	0.00111	0.00268	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—ICAM1—Behcet's disease	0.0011	0.00266	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—HLA-B—Behcet's disease	0.00103	0.0025	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—HLA-B—Behcet's disease	0.00103	0.0025	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—HLA-B—Behcet's disease	0.00103	0.0025	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—HLA-B—Behcet's disease	0.00102	0.00246	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CCR1—Behcet's disease	0.000929	0.00224	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CCR1—Behcet's disease	0.000929	0.00224	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCR1—Behcet's disease	0.000929	0.00224	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CCR1—Behcet's disease	0.000916	0.00221	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—CXCL8—Behcet's disease	0.000894	0.00216	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CTLA4—Behcet's disease	0.000849	0.00205	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CTLA4—Behcet's disease	0.000849	0.00205	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CTLA4—Behcet's disease	0.000849	0.00205	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—ICAM1—Behcet's disease	0.000841	0.00203	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—ICAM1—Behcet's disease	0.000841	0.00203	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—ICAM1—Behcet's disease	0.000841	0.00203	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CTLA4—Behcet's disease	0.000837	0.00202	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—ICAM1—Behcet's disease	0.000829	0.002	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—HLA-B—Behcet's disease	0.000828	0.002	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—APOB—Behcet's disease	0.000826	0.00199	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—HLA-B—Behcet's disease	0.000824	0.00199	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—APOB—Behcet's disease	0.000822	0.00198	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—CAT—Behcet's disease	0.000713	0.00172	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—CAT—Behcet's disease	0.00071	0.00171	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—APOB—Behcet's disease	0.000692	0.00167	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—APOB—Behcet's disease	0.000689	0.00166	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—ICAM1—Behcet's disease	0.000673	0.00162	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—ICAM1—Behcet's disease	0.00067	0.00162	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—APOA1—Behcet's disease	0.000654	0.00158	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—APOA1—Behcet's disease	0.000651	0.00157	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—HLA-B—Behcet's disease	0.000628	0.00151	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—HLA-B—Behcet's disease	0.000628	0.00151	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—HLA-B—Behcet's disease	0.000628	0.00151	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—APOB—Behcet's disease	0.000626	0.00151	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—APOB—Behcet's disease	0.000626	0.00151	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—APOB—Behcet's disease	0.000626	0.00151	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—TNF—Behcet's disease	0.000623	0.0015	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—HLA-B—Behcet's disease	0.000619	0.00149	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—APOB—Behcet's disease	0.000617	0.00149	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—APOB—Behcet's disease	0.000579	0.0014	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—APOB—Behcet's disease	0.000576	0.00139	CbGpPWpGaD
Carfilzomib—PSMB10—Gene Expression—SERPINE1—Behcet's disease	0.000559	0.00135	CbGpPWpGaD
Carfilzomib—PSMB9—Gene Expression—SERPINE1—Behcet's disease	0.000556	0.00134	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—APOA1—Behcet's disease	0.000548	0.00132	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—APOA1—Behcet's disease	0.000545	0.00131	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—CAT—Behcet's disease	0.00054	0.0013	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—CAT—Behcet's disease	0.00054	0.0013	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—CAT—Behcet's disease	0.00054	0.0013	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—CAT—Behcet's disease	0.000533	0.00128	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—APOB—Behcet's disease	0.000525	0.00127	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—APOB—Behcet's disease	0.000525	0.00127	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—APOB—Behcet's disease	0.000525	0.00127	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—SERPINE1—Behcet's disease	0.000519	0.00125	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—APOB—Behcet's disease	0.000517	0.00125	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—SERPINE1—Behcet's disease	0.000517	0.00125	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—ICAM1—Behcet's disease	0.00051	0.00123	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—ICAM1—Behcet's disease	0.00051	0.00123	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—ICAM1—Behcet's disease	0.00051	0.00123	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—ICAM1—Behcet's disease	0.000503	0.00121	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—APOA1—Behcet's disease	0.000496	0.0012	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—APOA1—Behcet's disease	0.000496	0.0012	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—APOA1—Behcet's disease	0.000496	0.0012	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—NOS3—Behcet's disease	0.000496	0.0012	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—NOS3—Behcet's disease	0.000493	0.00119	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—APOA1—Behcet's disease	0.000489	0.00118	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—APOA1—Behcet's disease	0.000458	0.0011	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—APOA1—Behcet's disease	0.000456	0.0011	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—APOB—Behcet's disease	0.000439	0.00106	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—APOB—Behcet's disease	0.000439	0.00106	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—APOB—Behcet's disease	0.000439	0.00106	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—APOB—Behcet's disease	0.000432	0.00104	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—SERPINE1—Behcet's disease	0.000424	0.00102	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—SERPINE1—Behcet's disease	0.000424	0.00102	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—SERPINE1—Behcet's disease	0.000424	0.00102	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—SERPINE1—Behcet's disease	0.000418	0.00101	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—APOA1—Behcet's disease	0.000415	0.001	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—APOA1—Behcet's disease	0.000415	0.001	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—NOS3—Behcet's disease	0.000415	0.001	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—APOA1—Behcet's disease	0.000415	0.001	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—NOS3—Behcet's disease	0.000413	0.000996	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—APOA1—Behcet's disease	0.000409	0.000987	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—SERPINE1—Behcet's disease	0.000393	0.000949	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—SERPINE1—Behcet's disease	0.000393	0.000949	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—SERPINE1—Behcet's disease	0.000393	0.000949	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—SERPINE1—Behcet's disease	0.000388	0.000935	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—NOS3—Behcet's disease	0.000376	0.000906	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—NOS3—Behcet's disease	0.000376	0.000906	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—NOS3—Behcet's disease	0.000376	0.000906	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—NOS3—Behcet's disease	0.00037	0.000893	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—SERPINE1—Behcet's disease	0.000363	0.000877	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—SERPINE1—Behcet's disease	0.000362	0.000872	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—APOA1—Behcet's disease	0.000347	0.000837	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—APOA1—Behcet's disease	0.000347	0.000837	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—APOA1—Behcet's disease	0.000347	0.000837	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—NOS3—Behcet's disease	0.000347	0.000837	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—NOS3—Behcet's disease	0.000345	0.000833	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—APOA1—Behcet's disease	0.000342	0.000825	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000329	0.000795	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—NOS3—Behcet's disease	0.000315	0.000759	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—NOS3—Behcet's disease	0.000315	0.000759	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—NOS3—Behcet's disease	0.000315	0.000759	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—NOS3—Behcet's disease	0.00031	0.000748	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CXCL8—Behcet's disease	0.000308	0.000742	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000307	0.000741	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CXCL8—Behcet's disease	0.000306	0.000739	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—SERPINE1—Behcet's disease	0.000275	0.000664	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—SERPINE1—Behcet's disease	0.000275	0.000664	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—SERPINE1—Behcet's disease	0.000275	0.000664	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—SERPINE1—Behcet's disease	0.000272	0.000655	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NOS3—Behcet's disease	0.000263	0.000634	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NOS3—Behcet's disease	0.000263	0.000634	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NOS3—Behcet's disease	0.000263	0.000634	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000261	0.000629	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NOS3—Behcet's disease	0.000259	0.000625	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CXCL8—Behcet's disease	0.000233	0.000563	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CXCL8—Behcet's disease	0.000233	0.000563	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CXCL8—Behcet's disease	0.000233	0.000563	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CXCL8—Behcet's disease	0.00023	0.000555	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CAT—Behcet's disease	0.000159	0.000383	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APOB—Behcet's disease	0.000154	0.000372	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APOA1—Behcet's disease	0.000122	0.000294	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—NOS3—Behcet's disease	9.25e-05	0.000223	CbGpPWpGaD
